Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Compugen Ltd. (CGEN)

« Back to company index

CGEN Chatter Timeline

Stock Ticker for CGEN

Most Active Tweeters for CGEN

UserTweets
@thefinreviewer 4
@BlogYomi 3
@whatsonthorold2 2
@mmahotstuff1 2
@StockNewsWires 1

Recent Tweets for CGEN

BlogYomi @BlogYomi
Comparing of OHR Pharmaceutical Inc. $CGEN https://t.co/0O1aqfdyUV
March 21st 2019, 1:03pm
mmahotstuff1 @mmahotstuff1
Compugen LTD. - Ordinary Shares $CGEN's Stock Is Sell After More Market Selling https://t.co/iRDHv2M1tu
March 21st 2019, 12:03pm
whatsonthorold2 @whatsonthorold2
Compugen LTD. - Ordinary Shares $CGEN Reports Increase in Sellers; Strong Momentum for Short Players https://t.co/hSDoMTUrS1
March 21st 2019, 12:03pm
StockTexts @StockTexts
$CGEN Compugen Ltd. SEC Filing: Form 20-F https://t.co/KygQQ2586a
March 21st 2019, 6:03am
BlogYomi @BlogYomi
Comparing of Bio-Techne Corporation $CGEN https://t.co/9GE72QUQFJ
March 20th 2019, 7:03pm
thefinreviewer @thefinreviewer
Evofem Biosciences Inc. $CGEN https://t.co/hnIW717CpL
March 19th 2019, 5:03pm
BlogYomi @BlogYomi
Reviewing Ionis Pharmaceuticals Inc. $CGEN's results https://t.co/v1W9QhH0KE
March 19th 2019, 4:03pm
mmahotstuff1 @mmahotstuff1
Time To Buy Compugen $CGEN? BidaskScore Upgrades Shares Today https://t.co/I4ziglF5MR
March 18th 2019, 9:03am
reurope_stock @reurope_stock
Analysts at BidaskScore Give Compugen $CGEN an Upgrade https://t.co/Cektnj1509
March 18th 2019, 9:03am
UlmHi @UlmHi
Comparing of Avid Bioservices Inc. $CGEN https://t.co/bYqG2QDys7
March 17th 2019, 11:03am
whatsonthorold2 @whatsonthorold2
Compugen LTD. - Ordinary Shares $CGEN’s Trend Unknown, Especially After Increased Shorts https://t.co/HziUgXP8dO
March 14th 2019, 3:03pm
StockNewsNow @StockNewsNow
$CGEN Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Pr… https://t.co/I69JhcqS6W
March 12th 2019, 11:03am
StockNewsWires @StockNewsWires
$CGEN: Compugen nabs two new patents in US for COM701; shares up 4 …: https://t.co/8uUvwHLaS0
March 12th 2019, 8:03am
MarketCurrents @MarketCurrents
$CGEN - Compugen nabs two new patents in U.S. for COM701; shares up 4% premarket https://t.co/G80Oz3ReF5
March 12th 2019, 8:03am
ProVesting @ProVesting
$CGEN: Compugen Announces Issuance of Two US Composition of Matter …: https://t.co/qVVpE5CdBw
March 12th 2019, 7:03am
bthefirsttoknow @bthefirsttoknow
$CGEN Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Pr… https://t.co/hhSonS9rV3
March 12th 2019, 7:03am
ChartMill @ChartMill
Compared to an average industry Altman-Z score of 1.53, $CGEN is more financially solid! https://t.co/XOgRa7dpst https://t.co/F5vdh4NebU
March 11th 2019, 1:03am
thefinreviewer @thefinreviewer
Contrasting of Intra-Cellular Therapies Inc. $CGEN https://t.co/ctuePnL6YF
March 10th 2019, 10:03pm
thefinreviewer @thefinreviewer
Reviewing Titan Pharmaceuticals Inc. $CGEN's results https://t.co/eqXa8yv4H3
March 10th 2019, 9:03pm
thefinreviewer @thefinreviewer
Comparing of Sage Therapeutics Inc. $CGEN https://t.co/k36XSxe2bu
March 10th 2019, 8:03pm
StockNewsNow @StockNewsNow
$CGEN Compugen to Present at the Cowen and Company 39th Annual Health Care Conference https://t.co/MQBwD72PnO
March 5th 2019, 10:03am
PRNewswireIL @PRNewswireIL
#Compugen to #Present at the #Cowen and #Company 39th #Annual #Health #Care #Conference https://t.co/MjGJ1vJGcP @CompugenInc $CGEN
March 5th 2019, 7:03am
VisualStockRSRC @VisualStockRSRC
$CGEN - Compugen to Present at the Cowen and Company 39th Annual Health Care Conference https://t.co/Fzua3pZCdK
March 5th 2019, 7:03am
TickerReport @TickerReport
Compugen $CGEN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/b0Y05H9NzC
March 5th 2019, 3:03am
dailypoliticaln @dailypoliticaln
Compugen $CGEN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/bkagDmdPO6
March 5th 2019, 3:03am
1stOncology @1stOncology
#Compugen Presents Update on #COM701 Phase 1 Trial at #ASCOSITC Clinical #ImmunoOncology Symposium $CGEN https://t.co/pCAGe1MjCI
March 4th 2019, 2:03am
ZolmaxNews @ZolmaxNews
Compugen $CGEN Stock Rating Upgraded by Zacks Investment Research https://t.co/Q2YZZBC0aa
March 4th 2019, 2:03am
TranscriptDaily @TranscriptDaily
Oppenheimer Comments on Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/0MMW3EEK02
March 3rd 2019, 9:03am
stocknewstimes @stocknewstimes
Oppenheimer Comments on Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/OR8FY4SRLQ
March 3rd 2019, 9:03am
mmahotstuff1 @mmahotstuff1
Compugen $CGEN Seems to Be a Stock That BidaskScore Is Excited About; Firm Upgrades Shares https://t.co/mPm0jkJig9
March 3rd 2019, 3:03am
whatsonthorold2 @whatsonthorold2
Will Today’s BidaskScore Upgrade Google Compugen $CGEN Shares? https://t.co/QyMRjq9EBy
March 3rd 2019, 3:03am
bibeypost_stock @bibeypost_stock
Is Compugen $CGEN Now a Buy? How Analysts Rate it and Why BidaskScore Upgraded The Stock https://t.co/3suAsGCiYZ
March 3rd 2019, 3:03am
reurope_stock @reurope_stock
Is Compugen $CGEN Now Worth Your Time and Dime After a Recent BidaskScore Upgrade? https://t.co/CX4EQctjwA
March 3rd 2019, 3:03am
PRNewswireIL @PRNewswireIL
#Compugen #Presents #Update on #COM701 #Phase 1 #Trial at #ASCO-SITC #Clinical #Immuno-Oncology #Symposium https://t.co/icJbKBbSLL $CGEN
March 3rd 2019, 3:03am
bbnsnews @bbnsnews
Compugen $CGEN PT Set at $9.00 by Oppenheimer https://t.co/Ng6CflRTmX
March 2nd 2019, 10:03pm
WeekHerald @WeekHerald
Compugen Ltd. Forecasted to Earn FY2023 Earnings of -$0.83 Per Share $CGEN https://t.co/VgAxIPVEBW
March 2nd 2019, 8:03pm
TheMarketsDaily @TheMarketsDaily
Compugen Ltd. Forecasted to Earn FY2023 Earnings of -$0.83 Per Share $CGEN https://t.co/XRE0DQ0QGm
March 2nd 2019, 8:03pm
registrarjourn @registrarjourn
Brokers Issue Forecasts for Compugen Ltd.’s Q1 2019 Earnings $CGEN https://t.co/FluloxPt8L
March 2nd 2019, 5:03pm
EnterpriseLeade @EnterpriseLeade
Brokers Issue Forecasts for Compugen Ltd.’s Q1 2019 Earnings $CGEN https://t.co/CIVOpEEB79
March 2nd 2019, 5:03pm
bbnsnews @bbnsnews
Compugen $CGEN Given a $9.00 Price Target by Oppenheimer Analysts https://t.co/JWmmUjkcCO
March 2nd 2019, 2:03pm
dakotafinancial @dakotafinancial
Compugen $CGEN Upgraded to “Strong-Buy” at Zacks Investment Research https://t.co/2Ahrgqq9ft
March 2nd 2019, 12:03pm
TranscriptDaily @TranscriptDaily
Compugen $CGEN Upgraded at Zacks Investment Research https://t.co/sKB0UtbCKi
March 2nd 2019, 12:03pm
jamaeze @jamaeze
RT @Crex_24: $CGEN coin was swapped into new CGEN coin. CGEN holders were credited with new CGEN coins. 1:100 ratio. #CGEN #swap @cgennetw…
March 2nd 2019, 6:03am
Crex_24 @Crex_24
$CGEN coin was swapped into new CGEN coin. CGEN holders were credited with new CGEN coins. 1:100 ratio. #CGEN… https://t.co/9cWdZje2z5
March 2nd 2019, 5:03am
TickerReport @TickerReport
Compugen Ltd. $CGEN to Post FY2023 Earnings of -$0.41 Per Share, Oppenheimer Forecasts https://t.co/rli7tREd8m
March 2nd 2019, 4:03am
dailypoliticaln @dailypoliticaln
Compugen Ltd. $CGEN to Post FY2023 Earnings of -$0.41 Per Share, Oppenheimer Forecasts https://t.co/nGI3gmlh5Y
March 2nd 2019, 4:03am
TheMarketsDaily @TheMarketsDaily
Compugen $CGEN Raised to “Strong-Buy” at Zacks Investment Research https://t.co/Z1UzHpG4Eo
March 1st 2019, 9:03pm
macondailynews @macondailynews
Compugen $CGEN Raised to “Strong-Buy” at Zacks Investment Research https://t.co/lY60JxFFpE
March 1st 2019, 9:03pm
bbnsnews @bbnsnews
Analysts Issue Forecasts for Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/FDkbgiCAmr
March 1st 2019, 4:03pm
AmericanBanking @AmericanBanking
Analysts Issue Forecasts for Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/GTr3mTcNE8 #stocks
March 1st 2019, 4:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.